文献速递老年与多病共存基层心理健康

老年抑郁患者服用镁剂替代处方的意愿调查

Older adults' willingness to take magnesium to treat depression.
PubMed 文献 · Ann Fam Med · 2022-04-01

该研究通过在线调查美国65岁及以上、PHQ-2提示有抑郁症状的社区老年人,发现83%的受访者愿意服用镁剂替代处方药治疗抑郁,89%愿意且感觉舒适地服用镁剂,73%认为镁剂能改善抑郁症状。女性更倾向于同意这些陈述(p<0.05),年龄和当前是否接受抑郁治疗无差异。

要点

  • 83%的抑郁症状老年人愿意用镁剂替代处方药治疗抑郁。
  • 89%愿意且感觉舒适地服用镁剂,73%认为镁剂能改善抑郁症状。
  • 女性比男性更倾向于同意上述陈述(p<0.05)。

核心结论

  • 多数社区居住的抑郁症状老年人愿意服用镁剂治疗抑郁。
  • 许多老年人每日已在服用至少一种非处方补充剂。

研究设计与样本

  • 在线调查,全国样本,对象为美国65岁及以上、PHQ-2提示有抑郁症状的成年人。
  • 共153名受访者,其中97名(63%)女性,143名(93%)白人,130名(85%)年龄65至75岁。

主要发现

  • 112名(73%)每日服用补充剂,其中15名(10%)服用镁剂。
  • 50名(33%)目前正在接受抑郁治疗。
  • 83%的受访者同意或强烈同意愿意服用镁剂替代处方药治疗抑郁。
  • 89%同意或强烈同意愿意服用镁剂治疗抑郁,89%感觉舒适,73%认为镁剂能改善抑郁症状。
  • 女性更可能同意这些陈述(p<0.05),年龄或当前抑郁治疗状态无差异。

关键数值与推荐

  • 主要结局为愿意服用镁剂替代处方药治疗抑郁,采用4点Likert量表(强烈同意至强烈不同意)。
  • 83%的受访者同意或强烈同意愿意服用镁剂替代处方药。

临床怎么用

  • 在基层医疗中,对于有抑郁症状的老年患者,可考虑询问其对镁剂等非处方补充剂的意愿。
  • 许多老年患者已在每日服用补充剂,临床沟通时可关注其补充剂使用情况。

局限性

  • 在线调查设计可能引入选择偏倚。
  • 样本以女性、白人、65至75岁为主,代表性有限。
  • 研究未评估镁剂的实际疗效,仅调查意愿和接受度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Depression affects up to 15% of community-dwelling older adults. Late-life depression is frequently underdiagnosed and undertreated. When depression in older adults is identified, up to 80% of treatment occurs in primary care. Currently available treatments have significant limitations (e.g., modest effectiveness, high costs, adverse effects, poor adherence, and social stigma), therefore additional treatment options are essential. Over the counter magnesium chloride is inexpensive, widely available, generally safe, well-absorbed, and was efficacious in prior studies, often within 2 weeks. OBJECTIVE: To collect background information on magnesium supplement use and acceptability in older adults with a depression. STUDY DESIGN: Online survey. DATASET: National sample. POPULATION STUDIED: Adults 65 and older living in the United States currently experiencing symptoms of depression based on Patient Health Questionnaire (PHQ- 2) results. OUTCOME MEASURES: The primary outcome was willingness to take magnesium supplements instead of prescription medication for the treatment of depression. Secondary measures included current supplement use, comfort level with taking magnesium to treat depression, and whether they think magnesium would help improve symptoms of depression. RESULTS: Of 153 respondents, 97 (63%) were female, 143 (93%) identified as white, and 130 (85%) were between the ages 65 and 75 years. 112 (73%) took a supplement daily, including 15 (10%) taking magnesium. 50 (33%) were currently being treated for depression. On a 4-point Likert scale ranging from "Strongly Agree" to "Strongly Disagree," 83% of respondents "Agreed" or "Strongly Agreed" in terms of their willingness to take magnesium instead of a prescription medication. A majority also "Agreed" or "Strongly Agreed" that they were willing (89%) and comfortable (89%) with taking magnesium to treat depression and also that it would improve symptoms of depression (73%). Women were more likely to agree with these statements (p<0.05), but there were no differences based on age or current treatment for depression. CONCLUSIONS: A majority of older community-dwelling adults are willing to take magnesium for the treatment of depression. Many adults are already taking at least 1 over the counter supplement daily. Further research is needed to determine the efficacy of magnesium supplements as an alternative treatment option in this population.

来源:Ann Fam Med,查看原文。版权归原作者所有。

引用

  1. Littenberg B, Natkin L, Tarleton E, et al. Older adults' willingness to take magnesium to treat depression. Ann Fam Med. 2022. PMID: 35904841. doi:10.1370/afm.20.s1.3075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。